Skip to main content Back to Top
Advertisement

11/16/2022

Amphetamine Mixed Salts, Extended-Release Capsules

Products Affected - Description

    • Amphetamine mixed salts extended release capsule, Camber, 10 mg, bottle, 100 count, NDC 31722-0186-01
    • Amphetamine mixed salts extended release capsule, Camber, 15 mg, bottle, 100 count, NDC 31722-0187-01
    • Amphetamine mixed salts extended release capsule, Camber, 20 mg, bottle, 100 count, NDC 31722-0188-01
    • Amphetamine mixed salts extended release capsule, Camber, 25 mg, bottle, 100 count, NDC 31722-0189-01
    • Amphetamine mixed salts extended release capsule, Camber, 30 mg, bottle, 100 count, NDC 31722-0195-01
    • Amphetamine mixed salts extended release capsule, Camber, 5 mg, bottle, 100 count, NDC 31722-0185-01
    • Amphetamine mixed salts extended release capsule, Par Pharmaceuticals, 10 mg, bottle, 100 count, NDC 49884-0840-01
    • Amphetamine mixed salts extended release capsule, Par Pharmaceuticals, 15 mg, bottle, 100 count, NDC 49884-0841-01
    • Amphetamine mixed salts extended release capsule, Par Pharmaceuticals, 20 mg, bottle, 100 count, NDC 49884-0842-01
    • Amphetamine mixed salts extended release capsule, Par Pharmaceuticals, 25 mg, bottle, 100 count, NDC 49884-0843-01
    • Amphetamine mixed salts extended release capsule, Par Pharmaceuticals, 30 mg, bottle, 100 count, NDC 49884-0844-01
    • Amphetamine mixed salts extended release capsule, Par Pharmaceuticals, 5 mg, bottle, 100 count, NDC 49884-0839-01
    • Amphetamine mixed salts extended release capsule, Rhodes, 10 mg, bottle, 100 count, NDC 42858-0610-10
    • Amphetamine mixed salts extended release capsule, Rhodes, 15 mg, bottle, 100 count, NDC 42858-0215-01
    • Amphetamine mixed salts extended release capsule, Rhodes, 20 mg, bottle, 100 count, NDC 42858-0720-01
    • Amphetamine mixed salts extended release capsule, Rhodes, 25 mg, bottle, 100 count, NDC 42858-0325-01
    • Amphetamine mixed salts extended release capsule, Rhodes, 30 mg, bottle, 100 count, NDC 42858-0930-01
    • Amphetamine mixed salts extended release capsule, Rhodes, 5 mg, bottle, 100 count, NDC 42858-0055-01
    • Amphetamine mixed salts extended release capsule, Sandoz, 10 mg, bottle, 100 count, NDC 00781-2335-01
    • Amphetamine mixed salts extended release capsule, Sandoz, 25 mg, bottle, 100 count, NDC 00781-2368-01
    • Amphetamine mixed salts extended release capsule, Sandoz, 30 mg, bottle, 100 count, NDC 00781-2371-01
    • Amphetamine mixed salts extended release capsule, Sun Pharma, 10 mg, bottle, 100 count, NDC 57664-0337-88
    • Amphetamine mixed salts extended release capsule, Sun Pharma, 15 mg, bottle, 100 count, NDC 57664-0338-88
    • Amphetamine mixed salts extended release capsule, Sun Pharma, 20 mg, bottle, 100 count, NDC 57664-0339-88
    • Amphetamine mixed salts extended release capsule, Sun Pharma, 25 mg, bottle, 100 count, NDC 57664-0340-88
    • Amphetamine mixed salts extended release capsule, Sun Pharma, 30 mg, bottle, 100 count, NDC 57664-0341-88
    • Amphetamine mixed salts extended release capsule, Sun Pharma, 5 mg, bottle, 100 count, NDC 57664-0336-88
    • Amphetamine mixed salts extended release capsule, Teva, 10 mg, bottle, 100 count, NDC 00228-3059-11
    • Amphetamine mixed salts extended release capsule, Teva, 15 mg, bottle, 100 count, NDC 00228-3063-11
    • Amphetamine mixed salts extended release capsule, Teva, 20 mg, bottle, 100 count, NDC 00228-3060-11
    • Amphetamine mixed salts extended release capsule, Teva, 25 mg, bottle, 100 count, NDC 00228-3064-11
    • Amphetamine mixed salts extended release capsule, Teva, 30 mg, bottle, 100 count, NDC 00228-3061-11
    • Amphetamine mixed salts extended release capsule, Teva, 5 mg, bottle, 100 count, NDC 00228-3062-11

Reason for the Shortage

    • Shire did not provide updated availability information for Adderall XR capsules.
    • Amneal has amphetamine mixed salts extended-release capsules available.
    • Camber did not provide a reason for the shortage.
    • Lannett has amphetamines mixed salts extended-release capsules available.
    • Mallincrodt refuses to provide availability information.
    • Par did not provide a reason for the shortage.
    • Prasco has amphetamine mixed salts extended-release capsules available for contracted customers.
    • Rhodes did not provide a reason for the shortage.
    • Sandoz did not provide a reason for the shortage.
    • Sun Pharma did not provide a reason for the shortage.
    • Teva did not provide a reason for the shortage.

Available Products

    • Amphetamine mixed salts extended release capsule, Amneal, 10 mg, bottle, 100 count, NDC 00115-1487-01
    • Amphetamine mixed salts extended release capsule, Amneal, 15 mg, bottle, 100 count, NDC 00115-1488-01
    • Amphetamine mixed salts extended release capsule, Amneal, 20 mg, bottle, 100 count, NDC 00115-1489-01
    • Amphetamine mixed salts extended release capsule, Amneal, 25 mg, bottle, 100 count, NDC 00115-1490-01
    • Amphetamine mixed salts extended release capsule, Amneal, 30 mg, bottle, 100 count, NDC 00115-1491-01
    • Amphetamine mixed salts extended release capsule, Amneal, 5 mg, bottle, 100 count, NDC 00115-1486-01
    • Amphetamine mixed salts extended release capsule, Lannett, 10 mg, bottle, 100 count, NDC 00527-5511-37
    • Amphetamine mixed salts extended release capsule, Lannett, 15 mg, bottle, 100 count, NDC 00527-5512-37
    • Amphetamine mixed salts extended release capsule, Lannett, 20 mg, bottle, 100 count, NDC 00527-5513-37
    • Amphetamine mixed salts extended release capsule, Lannett, 25 mg, bottle, 100 count, NDC 00527-5514-37
    • Amphetamine mixed salts extended release capsule, Lannett, 30 mg, bottle, 100 count, NDC 00527-5515-37
    • Amphetamine mixed salts extended release capsule, Lannett, 5 mg, bottle, 100 count, NDC 00527-5510-37
    • Amphetamine mixed salts extended release capsule, Prasco, 10 mg, bottle, 100 count, NDC 66993-0595-02
    • Amphetamine mixed salts extended release capsule, Prasco, 15 mg, bottle, 100 count, NDC 66993-0596-02
    • Amphetamine mixed salts extended release capsule, Prasco, 20 mg, bottle, 100 count, NDC 66993-0597-02
    • Amphetamine mixed salts extended release capsule, Prasco, 25 mg, bottle, 100 count, NDC 66993-0598-02
    • Amphetamine mixed salts extended release capsule, Prasco, 30 mg, bottle, 100 count, NDC 66993-0599-02
    • Amphetamine mixed salts extended release capsule, Prasco, 5 mg, bottle, 100 count, NDC 66993-0594-02
    • Amphetamine mixed salts extended release capsule, Sandoz, 15 mg, bottle, 100 count, NDC 00781-2343-01
    • Amphetamine mixed salts extended release capsule, Sandoz, 20 mg, bottle, 100 count, NDC 00781-2352-01
    • Amphetamine mixed salts extended release capsule, Sandoz, 5 mg, bottle, 100 count, NDC 00781-2329-01

Estimated Resupply Dates

    • Camber has all presentations on back order and the company cannot estimate a release date.
    • Par has all presentations on back order and the company cannot estimate a release date.
    • Rhodes has 5 mg, 20 mg, and 30 mg capsules in limited supply. The 10 mg, 15 mg, and 25 mg capsules are on back order and the company estimates a release date of early-2023.
    • Sandoz has 10 mg, 25 mg, and 30 mg capsules on back order and the company cannot estimate a release date.
    • Sun has all presentations on back order and the company estimates a release date in January 2023.
    • Teva has 5 mg capsules on back order and the company estimates a release date in mid- to late-December 2022. The 10 mg and 15 mg capsules are on back order and the company estimates release dates in late-November 2022. The 20 mg, 25 mg, and 30 mg capsules are on back order and the company estimates a release date in early-December 2022.

Updated

Updated November 16, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. Created August 24, 2022 by Leslie Jensen, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.